fbpx
Sign up now!
Don't show this again
Download the report!Continue to Site >
or wait 7 secs

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)

We’re glad you’re enjoying Pig Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app
X
Share
X

REPORTS

Collect articles and features into your own report to read later, print or share with others

Create a New Report

Favorites

Read Later

Create a new report

Report title (required) Brief description (optional)
CREATE
X
NEXT
PORK POULTRY
follow us


You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Pig Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Pig Health Today | Sponsored by Zoetis

.

Tag Archive: , , ,

M. hyo treatment with Draxxin® plays important role in SRD management

DISCOVERIES, Issue 14: Pigs treated for Mycoplasma hyopneumoniae (M. hyo) with a single dose of the injectable antimicrobial Draxxin® (tulathromycin) had significantly better average daily gain and...

Field studies demonstrate safety of Fostera® Gold PCV MH vaccine

DISCOVERIES, Issue 5: Fostera® Gold PCV MH, the new inactivated vaccine from Zoetis developed to provide the broadest protection available against porcine circovirus type 2 (PCV2), has been...

One dose of Draxxin® at weaning for SRD yields multiple benefit

DISCOVERIES, Issue 13: Pigs from herds with a natural outbreak of swine respiratory disease (SRD) had significantly better outcomes when they received just one injection of Draxxin® (tulathromycin)...

Antimicrobial’s unique attributes explain efficacy against key SRD pathogens

DISCOVERIES, Issue 12: The efficacy of Draxxin® (tulathromycin) against key swine respiratory disease (SRD) pathogens is largely due to the antimicrobial’s ability to reach and sustain high...

Don’t lose sight of M. hyo while battling other swine pathogens

TOOLBOX, Issue 1: An interview with Lucina Galina Pantoja, DVM, PhD, Director, Swine Technical Services, Zoetis 

Long duration of antibiotic helps improve clinical outcome after APP challenge

DISCOVERIES, Issue 10: Pigs treated with one intramuscular dose of Draxxin® (tulathromycin) and then challenged with a virulent strain of APP had significantly reduced mortality and lung lesions...

Chimera technology offers better path to protection for PCV2

DISCOVERIES, Issue 6: When PCV2 first became a problem in US swine herds, scientists looked at taking the immunogenic capsid gene from PCV2 and cloning it into the backbone of nonpathogenic PCV type...

Five steps to better Mycoplasma hyopneumoniae control

For pig producers and veterinarians, the health and economic impact of Mycoplasma hyopneumoniae is clear. In the US, enzootic pneumonia caused by M. hyo is considered one of the “big three”...

Pigs vaccinated with Fostera®PCV MH equally protected, weighed nearly 8 pounds more in large comparison trial

DISCOVERIES, Issue 1: Pigs vaccinated with Fostera® PCV MH were equally protected against porcine circovirus (PCV) type 2d as well as Mycoplasma hyopneumoniae (M. hyo) and weighed 7.78 pounds more...

M. hyo: Control or elimination?

Effective control of Mycoplasma hyopneumoniae (M. hyo) has to start in the breeding herd to prevent problems with the disease in finishers, according to Lucina Galina, DVM, director of technical...

Proposed classification system to improve M. hyo control tested in commercial setting

By Lucina Galina Pantoja, DVM, PhD, Director, swine technical services, Zoetis


You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.